top of page




NewBridge Pharmaceuticals (NBP) is a privately owned company founded in 2010 by a partnership between Venture Capitalists in San Francisco and Kuwait, namely the Kuwait Life Sciences Company and Kuwait Investment Authority. It is a specialty pharmaceutical company focused on in-licensing and commercializing USFDA & EMA approved innovative therapeutics that address unmet medical needs for the Middle East and N. Africa Region. NBP has in-licensed more than 20 products from small to medium biotech companies looking to access MENA through a regional partnership. NBP has achieved a successful track record in growing commercial business in the area of Oncology & Hematology, Immunology, Neuroscience, GI & Metabolic disease and Rare Disease.


Cincinnati Children logo.png

Cincinnati Children's ranks among the top five in the nation in U.S. News & World Report's 2021-22 listing of Best Children's Hospitals. A nonprofit, academic medical center established in 1883, Cincinnati Children's is one of the top three recipients of pediatric research grants from the National Institutes of Health. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education, and innovation. Additional information about technologies developed at Cincinnati Children's may be found at


As a mid-sized global biopharmaceutical company, Ipsen improves patients’ lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience. Improving people’s lives and health outcomes by focusing on areas of high unmet medical need, we are accelerating our momentum and rapidly boosting our pipeline to bring the full potential of our innovative medicines to patients.


We put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. Our partners collaborate with us because of our reputation for quality, our strong brand recognition, and our US FDA-inspected manufacturing plants. Organisations we work with know they can rely on us to deliver consistently, in all our markets. We have always been committed to high standards of ethical conduct. In our business and in our dealings with other people. At the heart of this are our three values: Innovation. Caring. Collaboration. These shape the way our people think, work and behave. And ensure the sustainability of our company. In 2017, we achieved the highest ranking of any pharmaceutical company in the UK’s Institute of Directors' Good Governance Report.



Among the most comprehensive and advanced health care systems in the world Our goal is to provide the best patient experience with every patient, every encounter, every time. UCLA Health is among the most comprehensive and advanced health care systems in the world. Our mission is to provide state-of-the-art patient care, generate research discoveries leading to new treatments and diagnoses, and train future generations of health care professionals. Together, the UCLA Hospital System and the David Geffen School of Medicine at UCLA strive every day to be a leader in setting the standards of excellence. We offer an integrated network of primary and specialty care services at more than 280 clinics across Southern California and the Central Coast and at five medical centers and hospitals – Ronald Reagan UCLA Medical Center, UCLA Mattel Children’s Hospital, the Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA, UCLA Santa Monica Medical Center and UCLA West Valley Medical Center. We enhance access by providing care at numerous affiliate sites and via community-based programs.

SANOFI - new.png

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.


We have been pioneering nutritional solutions since 1896, when our founders first began their early support of mothers and their infants. Since then, our nutritional solutions have transformed the lives of millions of people around the world. That pioneering spirit lives on today with an ongoing commitment to provide life-transforming nutrition at key moments throughout life.

nestle nutrition.png

We are Nestlé. The Good food, Good life company. We believe in the power of food to enhance lives. Good food nourishes and delights the senses. It helps pets to thrive, children to grow healthily and parents to age gracefully. It helps all of us to live life to the fullest. Good food also respects our planet and protects resources for future generations. But times are changing fast. And we know that what’s good today won’t be good enough tomorrow. Consider the challenge of satisfying the needs of 10 billion people by 2050 in a responsible and sustainable way. This will demand innovation and change. At Nestlé, we’re constantly pushing the boundaries of what’s possible with food, drink and nutritional health solutions. That way we can enhance quality of life and contribute to a healthier future for all. Today, our business has around 270,000 employees, more than 2,000 brands and a presence in 188 countries.


A Pioneering Spirit At Wyeth we were founded on an unwillingness to accept the status quo. We have pioneered infant and young child nutrition since 1915, consistently delivering scientifically-advanced nutrition & personalized solutions for pregnant women, infants and young kids. Simply put, we never compromise in the pursuit of progress. That’s because we serve the most uncompromising people in the world. Parents. And we’re proud to say it’s helped move us all forward. Our relentless challenging of science for the past 100 years has led to some of the most significant breakthroughs in infant nutrition. Our responsibility is not only to this generation of children, but to the generations to come, which is why our commitment to quality extends far beyond our products, to the communities we serve through our global and local initiatives. We’re not just nourishing children, we’re nourishing the future.

nestle health science.png

Built on decades of innovation and dedication, Nestlé Health Science was founded in 2011 by people passionate about the power of nutrition. Since then, we've changed a lot as a company, but our commitment to healthier lives certainly hasn't. From newborn babies to the most senior citizens, we provide nutrition and nourishment where it's needed most. And to achieve that, it all comes down to science. Through extensive research and development, working with healthcare providers and focusing on innovation, we’re bringing the latest advances in nutrition to the world, because we're committed to customers, patients and caregivers everywhere. We'll help them live their lives at their best—that's a promise.


Children’s Hospital of Philadelphia (CHOP).png

Children's Hospital of Philadelphia (CHOP) is the nation's first hospital devoted exclusively to the care of children. Since our start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic firsts in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives. Today, families facing complex conditions come to CHOP from all over the world, and our compassionate care and innovation has repeatedly earned us a spot on the U.S. News & World Report's Honor Roll of the nation's best children's hospitals.

NAPO new 2024 no bg.png

San Francisco, California-based Napo Pharmaceuticals, a Jaguar Health family company, focuses on developing innovative, patient-centric therapeutic solutions for essential supportive care and the management of neglected side effects across complicated disease states. Our goal is to redefine what is possible in supportive care, providing hope and improving outcomes for patients worldwide.


At Sandoz our work is focused on improving access to medicines, access to medical information and access to medical capacity building. At Sandoz, our purpose is to pioneer access for patients. Our business ambition is to be the world’s leading and most valued generics company. Our global portfolio comprises approximately 1 000 molecules, covering all a wide range of major therapeutic areas, which accounted for 2022 sales of USD 9.2 billion. Our broad offering translates into substantial and ongoing savings for patients and payors, which help to ensure the sustainability of healthcare systems in the face of significant budgetary pressures, while also freeing up funding for innovative medicines. Our products reach approximately 500 million patients every year. Our broad portfolio is spearheaded by our global leadership positions in both biosimilars, the “cutting edge” of innovative off-patent medicines, and generic antibiotics, the backbone of global healthcare systems.

Alphamed-high resolution logo.png

Alphamed was set up in 1982 by Dr. Saad F. Al Khayyat the company that was the foundation of Al Khayyat Investments. Al Khayyat Investments is on the threshold of a dynamic new phase of expansion, both domestically and regionally. Our financial position is strong. We have a committed, mature management team who have built on their rich, cumulative experience, gained across numerous geographies, to lead AKI into a position of strength in the UAE and beyond. Our infrastructure is powerful and well developed. Our vision is to retain our leading position in the market and grow further. Al Khayyat Investments trades across eight operating divisions, led by distinguished professionals drawn from a broad spectrum of industries AVANOS Medical is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. AVANOS Medical's products are designed to improve patient outcomes and enhance the efficiency of healthcare delivery. The company focuses on three core areas: pain management, airway management, and digestive health. AVANOS Medical's products for digestive health are designed to improve patient comfort and reduce the risk of complications associated with enteral feeding. The company works closely with healthcare providers to ensure that its products meet the needs of patients with different digestive health conditions.


Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines.


THERAVIA is a leading international pharmaceutical company specializing in rare or neglected diseases. Formed through the merger of Addmedica and CTRS, we are dedicated to address the unmet medical needs of patients with these challenging conditions. With a deep understanding of the unique challenges faced by individuals affected by rare diseases, we bring together the expertise and resources of Addmedica and CTRS to pioneer innovative therapies. Our mission is to make a tangible difference in the lives of patients, offering them hope and improved quality of life. At THERAVIA, we foster a culture of scientific excellence, driving collaboration among leading experts to pursue groundbreaking research and development. Our focus on rare or neglected diseases allows us to channel our efforts into areas of critical need, providing patients with much-needed options and renewed hope. Beyond our dedication to develop novel therapeutics, we actively engage with patient communities, advocacy groups, and healthcare professionals to ensure our efforts align with real-world needs. Upholding the highest standards of ethics, compliance, and patient safety, we strive to transform the landscape of rare diseases and make a positive impact. MECAPHARMA® develops, in-licenses, registers, promotes, sells and ensures quality, pharmacovigilance and medical information follow up of pharmaceutical products registered and/or available in the European and American continents. MECAPHARMA® has a global presence and an established multinational network of collaborators in the Middle East and North Africa (MENA) region, and beyond! MECAPHARMA® operates in complete transparency towards its partners and in complete discretion towards its market. MECAPHARMA® acts as sole exclusive agent, representing European and American pharmaceutical companies, registering their products as per respective MOH country requirements and legislations. MECAPHARMA® operates on behalf of its American and European partners as their own subsidiary would do. MECAPHARMA® registers its partner and their products, participates in national & regional tenders, initiates NPU sales, provides medical information, reports adverse events, trains field force, promotes the products upon registration and sells them at market agreed/registered price. In case of new opportunities, MECAPHARMA® business model allows to rapidly tailor new dedicated business units and train them in record time, hence beating any concomitant potential competitor.



Eurasia Invest Ltd has experience with Horse milk production since 2009 and is the biggest plant for production of freeze dried Horse milk powder in the world! The technological equipment used at the enterprise from European manufacturers allows us to strictly adhere to all modes of milk processing and fully comply with environmental and sanitary standards. Our product is a unique combination of the legacy of our ancestors with modern technology. This is the contribution of Kazakh nation to the global matter of human health.


Ordesa was foundation in Tamarite de Litera (Huesca) in 1943, since then Ordesa has always followed a policy of constant improvement, research and innovation. Our ambition to provide products to meet new needs has led us to evolve and grow as a company. Ordesa's purpose is to innovate in nutrition and health, because we care about your future. We want to accompany you at all stages of life, offering you nutrition and health products that improve your quality of life so that you can enjoy the future. We were pioneers in the introduction of innovative products in the Spanish market, such as the first hydrolyzed porridge, and we aspire to continue being a national and international benchmark.


Our journey, which started in Turkey in 2013, continues with our offices in Istanbul, Dubai and now Ghana. Currently, we deliver our products and services to approximately 20 countries, and we maintain our physical presence in 12 of these countries. We are growing rapidly with more than 100 employees who are competent in their fields, and we combine our innovative business approaches with medical experience, with the experience of more than a hundred years of experience of our doctors and pharmacists in our team. Our journey that started with medicine continues with the inclusion of non-pharmaceutical health solutions. With our partners in various countries of the world, we provide a wide range of services covering all areas from diagnosis to treatment. Our cooperation philosophy is based on transparency and coexistence within the framework of common goals, guided by our expertise. As TRPHARM, our mission that we have been loyal to since the first day is to bring together innovative solutions with health. Our vision, which we have created with our years of experience, is to be a global, innovative healthcare company. Our values that we take as a guide in each of our steps are to be in life, collaboration, balance and transformation.


Operation Smile UAE provides free surgeries to repair cleft lip, cleft palate and other facial anomalies to children around the world. Every 3 minutes, it is estimated that a child is born with a cleft lip or cleft palate. Approximately 1 in 700 children worldwide is born with a cleft lip, cleft palate or both.Children born with clefts are often unable to eat, speak, socialize or smile. With the help of medical volunteers and generous supporters, Operation Smile provides free surgeries for children around the world to heal their smiles and transform their lives. In as little as 45 minutes and for as little as 880 AED, Operation Smile can provide a life-changing surgery for a child in need. Operation Smile is known to provide free reconstructive surgeries for patients with facial deformities, especially with cleft lips and palates. But cleft care is not just surgery. It involves a lot of components from finding the patients, making sure they survive the first months of their life and are fit for surgery, ensuring they safely arrive at the mission site and are prepared for surgery and receive the necessary follow-up care. The Operation Smile team in the UAE is making the patient experience before, during and after surgery a top priority. Operation Smile UAE is engaging more hospitals and clinics throughout the UAE in order to increase comprehensive care for patients in all seven Emirates.

delta medical.png

“Combining local market expertise and the latest technological advancements, DME has been meeting the UAE’s ever-changing market needs for over 30 years.” Founded in 1985 in Abu Dhabi, Delta Medical Establishment (DME) is one of the UAE’s leading distribution agents for multinational products in the medical, wellness, health, and beauty sectors. Catering to over 3000 outlets in the UAE; including pharmacies, hospitals, clinics, wholesalers, supermarkets and various other retail outlets; DME is known for high-quality products and excellent service. Combining local market expertise and the latest technological advancements, DME has successfully been meeting the UAE’s ever-changing market needs for over 30 years. With a business model rooted in innovation and open communication, and acomprehensive understanding of the UAE’s consumer needs, the team at DME works endlessly to implement their knowledge to continuously enhance their services and product offerings. Through a holistic approach to distribution and logistical needs, DME provides a complete range of solutions with an array of complimentary services including sales, marketing, and healthcare management, designed to facilitate the acceleration of growth through tactical and strategic partnerships. DME, along with its sister companies, provides direct account coverage in all healthcare and consumer channels in the UAE, employing over 200 talented individuals.

Dupharm logo-high res 1 (1).png

Dupharm was established in 1994 as one of the leading distributor in UAE. We had created the best infrastructure and manpower resources to assure long-lasting relationship with our partners and customers.

quadri pharma.png

Quadri Pharma is a pharmaceutical business organization that was originally established in Egypt back in 1994. The organization was setup with the goal to provide professional and reliable technical services to principals while covering: registration, marketing & distribution of products in total compliance to local and international regulatory standards. In 2002, the organization was introduced to the United Arab Emirates market transferring the success outside Egypt to serve the regional demands. Quadri Pharmaceuticals Store LLC with offices in Abu Dhabi and Dubai offers quality products and services that includes but not limited to (Fertility , Life science and maintenance , Medical projects , Medical supplies ,Nutraceuticals & Pharmaceuticals

bottom of page